Kenmotsu H, Imamura CK, Kawamura T, Oyakawa T, et al. Prospective evaluation of the relationship between response and exposure of total and unbound erlotinib in non-small cell lung cancer patients. Cancer Chemother Pharmacol 2022 Jul 12. pii: 10.1007/s00280-022-04452.
PMID: 35821437